薬剤溶出ステント市場：薬剤コーティング、用途別-2025-2030年の世界予測

薬剤溶出ステント市場は、2023年に72億7,000万米ドルと評価され、2024年には80億5,000万米ドルに達すると予想され、CAGR 10.84%で成長し、2030年には149億4,000万米ドルに達すると予測されています。

薬剤溶出ステント（DES）は、冠動脈の動脈硬化性閉塞の再発を防ぐためにインターベンショナル・カーディオロジーで使用される特殊な冠動脈ステントです。これらのステントは薬物でコーティングされており、徐々に放出される薬物が細胞増殖を抑制し、血管の開存性を効果的に維持します。DESの必要性は、ベアメタルステントに伴う一般的な合併症である再狭窄を最小限に抑えることによって、経皮的冠動脈インターベンションの治療成績を改善する必要性から生じた。心臓病学で広く利用されているDESの用途は冠動脈疾患の治療にも及び、病院や心臓専門センターが主なエンドユーザーとなっています。DES市場の主な成長要因としては、世界の心血管疾患の有病率の上昇、人口の高齢化、ステントの有効性と生体適合性を高める技術の進歩などが挙げられます。さらに、新規薬剤製剤や生体吸収性ステントの研究が進んでいることも、有望な成長機会をもたらしています。企業は競争力を維持するために、戦略的パートナーシップを模索し、次世代ステントを開発するための研究に投資することができます。しかし、市場開拓は厳しい規制要件、DESの高コスト、償還の問題など、特に新興経済諸国での採用を妨げる課題に直面しています。また、ステント晩期血栓症のような合併症が起こり、抗血小板二重療法の延長が必要になることも、潜在的な制約のひとつです。新たな機会を捉えるために、企業は薬剤コーティングの技術革新、生分解性オプションの促進、ヘルスケアインフラが発展している未開拓市場での拡大に注力すべきです。市場競争は依然として激しく、製品開発における積極的な研究開発や、市場シェア拡大を目指した頻繁な合併・買収がその背景にあります。成功の鍵は、技術革新と費用対効果のバランス、規制状況への対応、患者の安全性への効果的な取り組みにあります。新興市場を戦略的にターゲットとし、最先端技術に投資することで、企業は薬剤溶出ステントのダイナミックな展望の中で大きな成長の可能性を活用することができます。

市場力学：急速に進化する薬剤溶出ステント市場の主要市場インサイトを公開

薬剤溶出ステント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 動脈疾患発症リスクの高まりに伴う老年人口の増加
  • 動脈硬化の有病率の上昇
  • 糖尿病や心停止などの慢性疾患の有病率の増加
• 市場抑制要因
  • 薬剤溶出ステントに関連するリスク
• 市場機会
  • 生体吸収性ステントのイントロダクションよる低侵襲手術のサポート
  • 新興国におけるヘルスケアインフラの改善
• 市場の課題
  • 製品回収に関する問題

ポーターの5つの力：薬剤溶出ステント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：薬剤溶出ステント市場における外部からの影響の把握

外部マクロ環境要因は、薬剤溶出ステント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析薬剤溶出ステント市場における競合情勢の把握

薬剤溶出ステント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス薬剤溶出ステント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬剤溶出ステント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨薬剤溶出ステント市場における成功への道筋を描く

薬剤溶出ステント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加に伴い、動脈疾患を発症するリスクも高まっている
    • 動脈硬化の有病率の上昇
    • 糖尿病や心停止などの慢性疾患の増加
  • 抑制要因
    • 薬剤溶出ステントに関連するリスク
  • 機会
    • 生体吸収性ステントのイントロダクションより低侵襲手術が可能に
    • 新興国におけるヘルスケアインフラの改善
  • 課題
    • 製品リコールに関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 薬剤溶出ステント市場ドラッグコーティング

• ポリマーフリーコーティング
  • 微細多孔質表面
  • マイクロ構造表面
  • ナノ多孔質表面
  • スロット付き管状表面
• ポリマーベースのコーティング
  • 生分解性ポリマー
  • 非生分解性ポリマー

第7章 薬剤溶出ステント市場：用途別

• 冠動脈疾患
• 末梢動脈疾患

第8章 南北アメリカの薬剤溶出ステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の薬剤溶出ステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの薬剤溶出ステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Alvimedica
• Arkray, Inc.
• B. Braun
• Biosensors International Group, Ltd.
• Biotronik
• Boston Scientific Corporation
• Cook Medical LLC
• HEXACATH
• KYOTO MEDICAL PLANNING Co., Ltd.
• Lepu Medical Technology（Beijing）Co., Ltd.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• REVA Medical LLC
• Shandong JW Medical Systems LTD.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. DRUG ELUTING STENT MARKET RESEARCH PROCESS
• FIGURE 2. DRUG ELUTING STENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG ELUTING STENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG ELUTING STENT MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MICRO POROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MICRO STRUCTURED SURFACE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NANOPOROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SLOTTED TUBULAR SURFACE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 35. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 36. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 37. CANADA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 57. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 58. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 59. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 61. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 62. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 63. INDIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 130. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 131. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 132. ITALY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 146. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 147. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 148. POLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 150. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 151. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 152. QATAR DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Eluting Stent Market was valued at USD 7.27 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 10.84%, to USD 14.94 billion by 2030.

Drug-eluting stents (DES) are specialized coronary stents used in interventional cardiology to prevent the recurrence of arteriosclerotic blockages in coronary arteries. These stents are coated with medication that is gradually released to inhibit cell proliferation, thus maintaining vessel patency effectively. The necessity for DES arises from the need to improve outcomes of percutaneous coronary interventions by minimizing restenosis, a common complication associated with bare-metal stents. Widely utilized in cardiology, their applications extend to treating coronary artery disease, and hospitals and specialized cardiac centers represent the primary end-users. Key growth factors for the DES market include the rising prevalence of cardiovascular diseases globally, an aging population, and technological advancements that enhance stent efficacy and biocompatibility. Furthermore, ongoing research into novel drug formulations and bioresorbable stents offers promising growth opportunities. Companies could explore strategic partnerships and invest in research to develop next-generation stents to remain competitive. However, market growth faces challenges such as stringent regulatory requirements, high costs of DES, and reimbursement issues that could hinder adoption, especially in developing economies. Potential limitations also include complications like late stent thrombosis, necessitating extended dual antiplatelet therapy. To capture emerging opportunities, businesses should focus on innovation in drug coatings, promoting biodegradable options, and expanding in underserved markets with growing healthcare infrastructure. The market remains highly competitive, underscored by aggressive R&D in product development and frequent mergers and acquisitions aimed at expanding market share. Success relies on the ability to balance innovation with cost-effectiveness, navigating regulatory landscapes, and effectively addressing patient safety concerns. By strategically targeting emerging markets and investing in cutting-edge technologies, companies can leverage significant growth potential within the dynamic landscape of drug-eluting stents.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Stent Market

The Drug Eluting Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population along with growing high risk of developing arterial diseases
  • Rising prevalence rate of atherosclerosis
  • Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
• Market Restraints
  • Risks associated with drug eluting stent
• Market Opportunities
  • Introduction of bio resorbable stents support minimally invasive surgeries
  • Improving healthcare infrastructure in emerging economies
• Market Challenges
  • Issues related to product recall

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Stent Market

A detailed market share analysis in the Drug Eluting Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Eluting Stent Market

A strategic analysis of the Drug Eluting Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Arkray, Inc., B. Braun, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical LLC, HEXACATH, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical LLC, Shandong JW Medical Systems LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Coating, market is studied across Polymer Free Coatings and Polymer-Based Coatings. The Polymer Free Coatings is further studied across Micro Porous Surface, Micro Structured Surface, Nanoporous Surface, and Slotted Tubular Surface. The Polymer-Based Coatings is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.
• Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population along with growing high risk of developing arterial diseases
    • 5.1.1.2. Rising prevalence rate of atherosclerosis
    • 5.1.1.3. Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with drug eluting stent
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of bio resorbable stents support minimally invasive surgeries
    • 5.1.3.2. Improving healthcare infrastructure in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Issues related to product recall
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Eluting Stent Market, by Drug Coating

• 6.1. Introduction
• 6.2. Polymer Free Coatings
  • 6.2.1. Micro Porous Surface
  • 6.2.2. Micro Structured Surface
  • 6.2.3. Nanoporous Surface
  • 6.2.4. Slotted Tubular Surface
• 6.3. Polymer-Based Coatings
  • 6.3.1. Biodegradable Polymers
  • 6.3.2. Non-Biodegradable Polymers

7. Drug Eluting Stent Market, by Application

• 7.1. Introduction
• 7.2. Coronary Artery Disease
• 7.3. Peripheral Artery Disease

8. Americas Drug Eluting Stent Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Drug Eluting Stent Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Drug Eluting Stent Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alvimedica
• 3. Arkray, Inc.
• 4. B. Braun
• 5. Biosensors International Group, Ltd.
• 6. Biotronik
• 7. Boston Scientific Corporation
• 8. Cook Medical LLC
• 9. HEXACATH
• 10. KYOTO MEDICAL PLANNING Co., Ltd.
• 11. Lepu Medical Technology (Beijing) Co., Ltd.
• 12. Medtronic PLC
• 13. Meril Life Sciences Pvt. Ltd.
• 14. MicroPort Scientific Corporation
• 15. REVA Medical LLC
• 16. Shandong JW Medical Systems LTD.
• 17. Terumo Corporation